Delivery Order SPE2DB24D1205-SPE2DB25FCWCW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of OFEV 150 mg capsules (60-count units) under a firm fixed-price arrangement. The contract, valued at $8,590.58, was competitively awarded without any set-aside designation and carries an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) under a firm fixed-price contract valued at $8,630.28. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,630.28 for OFEV 100 mg capsules (60-count) on August 27, 2025, with completion expected by September 18, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor, leveraging the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on July 31, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) under a firm fixed price contract. The award was made on July 21, 2025, with an ultimate completion date of August 11, 2025. The contract utilizes no set-aside designation and represents a competitive award to the pharmaceutical distributor, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) with a ceiling value of $8,630.28. This firm fixed price delivery order, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) under a firm fixed price contract valued at $17,181.16. The order, issued on September 8, 2025, is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order that reflects the company's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV (pirfenidone) 100 mg capsules, 60-count packages, valued at $17,260.58 under a firm fixed-price contract type. This award, issued on July 31, 2025, represents a non-competitive delivery order for pharmaceutical supply with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OFEV 150 MG CAPSULE 60S, a pharmaceutical product, with a ceiling value of $7,905.56. The contract has an ultimate completion date of April 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCWCWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) under a firm fixed-price contract valued at $8,630.28, with an ultimate completion date of May 15, 2025. This non-set-aside award was competitively procured and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as the prime contractor on this delivery order. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other government health systems worldwide. The company's federal contract portfolio demonstrates significant capacity in pharmaceutical procurement across multiple therapeutic domains, positioning it as a key vendor for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 4/24/25 |